[1]Kellum J A, Romagnani P, Ashuntantang G, et al. Acute kidney injury[J]. Nature Reviews Disease Primers, 2021, 7(1): 52.
[2]Levey A S, James M T. Acute Kidney Injury[J]. Annals of Internal Medicine, 2017, 167(9): ITC66-ITC80.
[3]Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol, 2018, 14(10): 607-625.
[4]Xu X, Nie S, Liu Z, et al. Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults[J]. Clinical Journal of the American Society of Nephrology, 2015, 10(9): 1510-1518.
[5]Rewa O, Bagshaw S M. Acute kidney injury—epidemiology, outcomes and economics[J]. Nature Reviews Nephrology, 2014, 10(4): 193-207.
[6]Tandukar S, Palevsky P M. Continuous Renal Replacement Therapy[J]. Chest, 2019, 155(3): 626-638.
[7]Klein SJ, Brandtner AK, Lehner GF, et al. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med, 2018, 44(3): 323-336.
[8]Joannidis M, Forni LG. Clinical review: timing of renal replacement therapy. Crit Care, 2011, 15(3): 223.
[9]Ronco C, Bellomo R, Kellum J A. Acute kidney injury[J]. The Lancet, 2019, 394(10212): 1949-1964.
[10]KDIGO AKI Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2012, 2: 1-138.
[11]Zarbock A, Kellum J A, Schmidt C, et al. Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury[J]. Jama, 2016, 315(20): 2190-9.
[12]Gaudry S, Hajage D, Schortgen F, et al. Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit[J]. New England Journal of Medicine, 2016, 375(2): 122-133.
[13]STARRT-AKI Investigators. STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury: Study Protocol for a Multi-National, Multi-Center, Randomized Controlled Trial. Can J Kidney Health Dis. 2019, 6: 2054358119852937.
[14]Barbar S D, Clere-Jehl R, Bourredjem A, et al. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis[J]. New England Journal of Medicine, 2018, 379(15): 1431-1442.
[15]Ostermann M, Zarbock A, Goldstein S, et al. Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference[J]. JAMA Network Open, 2020, 3(10): e2019209.
[16]Ostermann M, Bellomo R, Burdmann E A, et al. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference[J]. Kidney International, 2020, 98(2): 294-309.
[17]Chawla L S, Ronco C. Renal Stress Testing in the Assessment of Kidney Disease[J]. Kidney International Reports, 2016, 1(1): 57-63.
[18]Ellison D H. Clinical Pharmacology in Diuretic Use[J]. Clinical Journal of the American Society of Nephrology, 2019, 14(8): 1248-1257.
[19]Brater D C. Clinical Pharmacology of Loop Diuretics[J]. Drugs, 1991, 41(3): 14-22.
[20]Chawla L S, Davison D L, Brasha-Mitchell E, et al. Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury[J]. Critical Care, 2013, 17(5): R207.
[21]Baek SM, Brown RS, Shoemaker WC. Early prediction of acute renal failure and recovery. II. Renal function response to furosemide. Ann Surg. 1973, 178(5): 605-8.
[22]Rewa O G, Bagshaw S M, Wang X, et al. The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: A multicenter, prospective, observational study[J]. Journal of Critical Care, 2019, 52: 109-114.
[23]Pon A G, Vairakkani R, Mervin E F, et al. Clinical significance of frusemide stress test in predicting the severity of acute kidney injury[J]. Brazilian Journal of Nephrology, 2021, 43(4): 470-477.
[24]Koyner J L, Davison D L, Brasha-Mitchell E, et al. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity[J]. Journal of the American Society of Nephrology, 2015, 26(8): 2023-2031.
[25]Lumlertgul N, Peerapornratana S, Trakarnvanich T, et al. Early versus standard initiation of renal replacement therapy in furosemide stress test non-responsive acute kidney injury patients (the FST trial)[J]. Critical Care, 2018, 22(1): 101.
[26]窦志敏, 李红, 朱磊, 等. 呋塞米负荷试验对急性肾损伤患者启动肾脏替代治疗的预测价值[J]. 中国急救医学, 2018, 38(07): 586-589+651.
[27]Zhang K, Zhang H, Zhao C, et al. The furosemide stress test predicts the timing of continuous renal replacement therapy initiation in critically ill patients with acute kidney injury: a double-blind prospective intervention cohort study[J]. European Journal of Medical Research, 2023, 28(1): 149.
[28]Sakhuja A, Bandak G, Barreto E F, et al. Role of Loop Diuretic Challenge in Stage 3 Acute Kidney Injury[J]. Mayo Clinic Proceedings, 2019, 94(8): 1509-1515.
[29]Das PK, Maurya SK, Nath SS, et al. Furosemide Stress Test and Renal Resistive Index for Prediction of Severity of Acute Kidney Injury in Sepsis. Cureus, 2023, 15(8): e44408.
[30]Chen J-J, Chang C-H, Huang Y-T, et al. Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis[J]. Critical Care, 2020, 24(1): 202.
[31]Meersch M, Weiss R, Gerss J, et al. Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients[J]. Critical Care Medicine, 2023, 51(8): 1033-1042.
[32]Mariano F, Mella A, Vincenti M, et al. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug[J]. Journal of Nephrology, 2019, 32(6): 883-893.
[33]Ronco C, Chawla L S. Glomerular and Tubular Kidney Stress Test: New Tools for a Deeper Evaluation of Kidney Function[J]. Nephron, 2016, 134(3): 191-194.
[34]Hernández F J L. The furosemide stress test: Perspectives for acute kidney injury diagnosis[J]. Brazilian Journal of Nephrology, 2021, 43(4): 452-454.
[35]Jensen I S, Larsen C K, Leipziger J, et al. Na+ dependence of K+‐induced natriuresis, kaliuresis and Na+/Cl? cotransporter dephosphorylation [J]. Acta Physiologica, 2016, 218(1): 49-61.
[36]Pon A G, Vairakkani R, Merwin E F, et al. Clinical significance of frusemide stress test in predicting the severity of acute kidney injury [J]. Brazilian Journal of Nephrology, 2021, 43(4): 470-7.
[37]Matsuura R, Komaru Y, Miyamoto Y, et al. Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels [J]. Annals of Intensive Care, 2018, 8(1): 8.
[38]Bolgiaghi L, Umbrello M, Formenti P, et al. The furosemide stress test, electrolyte response and Renal Index in critically ill patients [J]. Minerva Anestesiologica, 2021, 87(4): 448-457.
[39]Mariano F, Leporati M, Carignano P, et al. Urine volume as a predicting factor for furosemide clearance during continuous infusion in AKI septic shock patients on hemodiafiltration [J]. Journal of Nephrology, 2018, 31(6): 889-97.
[40]Borasino S, Wall K M, Crawford J H, et al. Furosemide Response Predicts Acute Kidney Injury After Cardiac Surgery in Infants and Neonates [J]. Pediatric Critical Care Medicine, 2018, 19(4): 310-7.
[41]Penk J, Gist K M, Wald E L, et al. Furosemide response predicts acute kidney injury in children after cardiac surgery [J]. The Journal of Thoracic and Cardiovascular Surgery, 2019, 157(6): 2444-51.
[42]Kakajiwala A, Kim J Y, Hughes J Z, et al. Lack of Furosemide Responsiveness Predicts Acute Kidney Injury in Infants After Cardiac Surgery [J]. The Annals of Thoracic Surgery, 2017, 104(4): 1388-94.
[43]McMahon B A, Koyner J L, Novick T, et al. The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation [J]. Biomarkers, 2017, 23(1): 61-9.
[44]Udomkarnjananun S, Townamchai N, Iampenkhae K, et al. Furosemide Stress Test as a Predicting Biomarker for Delayed Graft Function in Kidney Transplantation [J]. Nephron, 2019, 141(4): 236-48.
[45]Solís, Gerardo & Sánchez-Díaz, Salvador & Molina, Moisés &, et al. Furosemide stress test to predict success or failure to remove continuos slow renal replacement therapy in acute renal injury [J]. Medicina Crítica, 2018, 32: 85-92.
[46]Rivero J, Rodríguez F, Soto V, et al. Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease [J]. BMC Nephrology, 2020, 21(1): 87.
